Divestitures

6 Months Ended

Mar. 31, 2012

Divestitures [Abstract]

Divestitures

Note 10 – Divestitures

In the fourth quarter of fiscal year 2010, the Company sold the Ophthalmic Systems unit and the surgical blades, critical care and extended dwell catheter product platforms for $270,000. The Company recognized a pre-tax gain on sale from all of these divestitures of $146,478.

The results of operations associated with the Ophthalmic Systems unit, surgical blade platform and critical care platform are reported as discontinued operations for all periods presented in the accompanying Consolidated Statements of Income and Cash Flows and related disclosures. The Company agreed to perform contract manufacturing for a defined period after the sale of the extended dwell catheter product platform. Due to this significant continuing involvement in operations, the associated results of operations were reported within continuing operations and $18,197 of the gain on sale was recognized in Other income (expense).

Results of discontinued operations were as follows:

	Three Months Ended March  31,					Six Months Ended March 31,
	2012			2011		2012			2011
Revenues	$	22		$	119	$	70		$	3,007
Income from discontinued operations before income taxes		345			1,334		301			3,218
Less income tax (benefit) provision		(140	)		377		(159	)		601
Income from discontinued operations, net	$	485		$	957	$	460		$	2,617